Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study

Mathias Møllebæk, Helga Gardarsdottir, Alexia-Georgia Bikou, Ana Kodrič, Ana Marta Silva, Armin Andersen, Christos Kontogiorgis, Elita Poplavska, Fariba Ahmadizar, Foteini Dermiki-Gkana, Ieva Rutkovska, Inês Ribeiro Vaz, Mitja Kos, Paula Barão, Renske Grupstra, Teresa Leonardo Alves, Anna Birna Almarsdóttir

Open source

DOI: 10.1007/s40264-024-01487-5
Published: 2024-11-21
Container: Drug Safety
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40264-024-01487-5,
  title = {Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study},
  author = {Mathias Møllebæk and Helga Gardarsdottir and Alexia-Georgia Bikou and Ana Kodrič and Ana Marta Silva and Armin Andersen and Christos Kontogiorgis and Elita Poplavska and Fariba Ahmadizar and Foteini Dermiki-Gkana and Ieva Rutkovska and Inês Ribeiro Vaz and Mitja Kos and Paula Barão and Renske Grupstra and Teresa Leonardo Alves and Anna Birna Almarsdóttir},
  year = {2024},
  journal = {Drug Safety},
  doi = {10.1007/s40264-024-01487-5},
  url = {https://doi.org/10.1007/s40264-024-01487-5}
}

RIS

TY  - JOUR
TI  - Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study
AU  - Mathias Møllebæk
AU  - Helga Gardarsdottir
AU  - Alexia-Georgia Bikou
AU  - Ana Kodrič
AU  - Ana Marta Silva
AU  - Armin Andersen
AU  - Christos Kontogiorgis
AU  - Elita Poplavska
AU  - Fariba Ahmadizar
AU  - Foteini Dermiki-Gkana
AU  - Ieva Rutkovska
AU  - Inês Ribeiro Vaz
AU  - Mitja Kos
AU  - Paula Barão
AU  - Renske Grupstra
AU  - Teresa Leonardo Alves
AU  - Anna Birna Almarsdóttir
PY  - 2024
JO  - Drug Safety
DO  - 10.1007/s40264-024-01487-5
UR  - https://doi.org/10.1007/s40264-024-01487-5
ER  -

APA

Møllebæk, M., Gardarsdottir, H., Bikou, A., Kodrič, A., Silva, A. M., Andersen, A., Kontogiorgis, C., Poplavska, E., Ahmadizar, F., Dermiki-Gkana, F., Rutkovska, I., Vaz, I. R., Kos, M., Barão, P., Grupstra, R., Alves, T. L., & Almarsdóttir, A. B. (2024). Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study. Drug Safety. https://doi.org/10.1007/s40264-024-01487-5

Source records

crossref · retrieved 2026-09-27T10:10:11.605Z